Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C47H70O14 |
| Molecular Weight | 859.0503 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@H](C[C@@H]2OC)O[C@H]3[C@@H](C)\C=C\C=C4/CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O[C@H]6C[C@@H](C\C=C3/C)O[C@@]7(C6)O[C@H](C(C)C)[C@@H](C)C=C7)[C@]45O)O[C@@H](C)[C@@H]1O
InChI
InChIKey=ZFUKERYTFURFGA-PVVXTEPVSA-N
InChI=1S/C47H70O14/c1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h11-14,16-18,24-25,27,29-30,32-44,48-49,51H,15,19-23H2,1-10H3/b12-11+,26-14+,31-13+/t25-,27-,29-,30-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42-,43-,44+,46+,47+/m0/s1
| Molecular Formula | C47H70O14 |
| Molecular Weight | 859.0503 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Abamectin B1b (Avermectin B1b) is a macrocyclic lactone containing an isopropyl reside in the 25-position broad anthelmintic activity. The oral administration of this formulation of avermectin B1 appeared to be highly efficacious against intestinal strongyles and Onchocera microfilaria. Avermectin B1b is a component of marketed and provided commercially Abamectin, which is used to control livestock parasitic nematodes. It is a broad-spectrum acaricide with additional insecticidal action on a limited number of insects. Abamectin acts on insects by increasing the membrane permeability to chloride ions, and it mainly stimulates the release of Ȗ-aminobutyric acid (GABA). The affected arthropod becomes paralysed, stops feeding, and dies after a few days. It exerts contact and stomach action, with limited plant systemic activity, but exhibits translaminar movement into treated leaves. Abamectin is also used as an anthelmintic drug in veterinary medicine.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2085293
Horses: avermectin B1 solution (0.2 mg/kg p.o.). The avermectin B1 was a 1% solution in a propylene glycolglycerol formal base.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:46:16 GMT 2025
by
admin
on
Mon Mar 31 18:46:16 GMT 2025
|
| Record UNII |
W8DT67027W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000024013
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
265-611-9
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
65195-56-4
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
W8DT67027W
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
DTXSID4058239
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL2079552
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
6858005
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY | |||
|
29537
Created by
admin on Mon Mar 31 18:46:16 GMT 2025 , Edited by admin on Mon Mar 31 18:46:16 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|